EUVIMEDEUVIMED entdecken
Crossref

Risk of map‐like redness development after eradication therapy for Helicobacter pylori infection

Sho Matsumoto, Mitsushige Sugimoto iD, Masakatsu Fukuzawa, Nana Uesugi, Eri Iwata iD, Yasuyuki Kagawa, Akira Madarame, Yohei Koyama, Takashi Morise, Kumiko Uchida, Hayato Yamaguchi, Shin Kono und 3 weitere

Helicobacter · 2024

DOI: 10.1111/hel.13046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Helicobacter, 2024. Verfasst von Sho Matsumoto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Tokyo Medical University Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Helicobacter Infections, Gastritis, Helicobacter pylori. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Map‐like redness is a newly identified endoscopic risk factor for gastric cancer in patients who received Helicobacter pylori eradication therapy. However, the incidence rate of map‐like redness in patients who received eradication, and the risk factors for the development of map‐like redness remain unclear. We hence aimed to investigate the incidence rate of map‐like redness at 1‐year post H. pylori eradication, and evaluated its associations with map‐like redness and gastric cancer in relation with gastric condition. Materials and Methods Endoscopic severity of gastritis and map‐like redness were retrospectively evaluated according to the Kyoto Classification of Gastritis in patients who had undergone endoscopy before and after H. pylori eradication therapy.

Results

The incidence rate of map‐like redness for all 328 patients at a mean of 1.2 ± 0.6 years after eradication was 25.3% (95% confidence interval [CI]: 20.7%–30.4%). Patients who developed map‐like redness were older, had more severe atrophy and intestinal metaplasia, a higher total score of the Kyoto Classification of Gastritis both before and after eradication, and a higher rate of gastric cancer history than patients who did not have map‐like redness. On multivariate analysis, risk of map‐like redness was increased in patients with intestinal metaplasia (odds ratio [OR]: 2.794, 95% CI: 1.155–6.757) and taking acid inhibitors (OR: 1.948, 95% CI: 1.070–3.547). Characteristics of H. pylori ‐positive patients with gastric cancer history were patients who were older (OR: 1.033, 95% CI: 1.001–1.066), taking acid inhibitors (OR: 4.456, 95% CI: 2.340–8.484), and with occurrence of map‐like redness after eradication therapy (OR: 2.432, 95% CI: 1.264–4.679).

Conclusions

Map‐like redness is observed in one fourth of patients at 1‐year post eradication. Patients who developed map‐like redness were found to have severe intestinal metaplasia and taking acid inhibitors, and hence such patients require increased attention at surveillance endoscopy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsGastritisHelicobacter pyloriHumansMaleFemaleMiddle AgedRetrospective StudiesRisk FactorsAgedAdultStomach NeoplasmsIncidenceAnti-Bacterial Agents

Stichwörter der Autor:innen

Helicobacter pyloriatrophyeradication therapygastric cancerintestinal metaplasiamap‐like redness

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Tokyo Medical University Hospital, Tokyo, Japan.
  • Department of Gastroenterological Endoscopy, Tokyo Medical University Hospital, Tokyo, Japan.
  • Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

ORCID-Profile: Mitsushige Sugimoto, Eri Iwata

Zitieren

APA

Matsumoto, S., Sugimoto, M., Fukuzawa, M., Uesugi, N., Iwata, E., Kagawa, Y., Madarame, A., Koyama, Y., Morise, T., Uchida, K., Yamaguchi, H., Kono, S., Naito, S., Kawai, T., & Itoi, T. (2024). Risk of map‐like redness development after eradication therapy for Helicobacter pylori infection. Helicobacter. https://doi.org/10.1111/hel.13046

Vancouver

Matsumoto S, Sugimoto M, Fukuzawa M, Uesugi N, Iwata E, Kagawa Y, et al. Risk of map‐like redness development after eradication therapy for Helicobacter pylori infection. Helicobacter. 2024. doi:10.1111/hel.13046

BibTeX
@article{Matsumoto2024,
  author = {Matsumoto, Sho and Sugimoto, Mitsushige and Fukuzawa, Masakatsu and Uesugi, Nana and Iwata, Eri and Kagawa, Yasuyuki and Madarame, Akira and Koyama, Yohei and Morise, Takashi and Uchida, Kumiko and Yamaguchi, Hayato and Kono, Shin and Naito, Sakiko and Kawai, Takashi and Itoi, Takao},
  title = {Risk of map‐like redness development after eradication therapy for Helicobacter pylori infection},
  journal = {Helicobacter},
  year = {2024},
  doi = {10.1111/hel.13046}
}
Kostenlos starten →